Join
Live feed
·
INSIDERFilingvia Quantisnow
Global Blood Therapeutics Inc. logo

SEC Form 4: Patrick Deval L converted options into 3,600 shares, increasing direct ownership by 66% to 9,037 units

ByQuantisnow·Wall Street's wire, on your screen.
GBT· Global Blood Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GBT (Global Blood Therapeutics Inc.) and more on Quantisnow.